Vaccine Contract Manufacturing Market Size Worth $4.0 Billion by 2025: Grand View Research, Inc.
SAN FRANCISCO, February 21, 2018 /PRNewswire/ --
The global vaccine contract manufacturing market size is expected to reach USD 4.0 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a 9.3% CAGR during the forecast period. The market is anticipated to witness significant growth over the coming years thanks to rising demand for vaccine development from the private sector as well as governments in industrialized and developing countries.
Vaccine contract services offer cost-saving benefits to their clients. They also help save time in operations and management of a production and research facility. These advantages associated with Contract Manufacturing Organizations (CMOs) are expected to benefit emerging players, start-ups, and small players who lack adequate facilities and resources required for vaccine development.
Increase in pricing pressure, regulatory challenges, and patent expiration in recent times are expected to adversely impact the market. Contract services are considered "strategic competitive weapons" among vaccine manufacturers as they help overcome the aforementioned issues.
A number of international healthcare organizations are engaged in estimating and predicting the quantity of goods as well as financial need required for conducting immunization programs. Some of the factors considered for this estimation are quantity of vaccines, estimated time of delivery, product type, and vial size. Participation of international healthcare organizations in vaccination programs is expected to positively influence the growth of contract manufacturers.
Browse full research report with TOC on"Vaccine Contract Manufacturing Market Analysis Report By Vaccine Type (Attenuated, Inactivated, Subunit, Toxoid, DNA), By Workflow (Downstream, Upstream), By Application (Human, Veterinary), And Segment Forecasts, 2014 - 2025" at:https://www.grandviewresearch.com/industry-analysis/vaccine-contract-manufacturing-market
Further Key Findings From the Report Suggest:
Contract services for development of attenuated vaccines accounted for the major share in the market based on vaccine type. This can be attributed to the fact that these vaccines offer immunity for a lifetime with only one or two doses
DNA vaccines form the fastest-growing segment by type, with several kinds already being tested on humans
Based on workflow, downstream processing dominated the market mainly due to the necessity of mature and reliable biotechnology tools for product recovery. Various research initiatives in the space are also contributing in advancing downstream workflows
By application, contract services for the development of human-use vaccines held the largest share owing to their high adoption to develop vaccines against influenza and other illnesses
Lonza; IDT Biologika GmbH; FUJIFILM Diosynth Biotechnologies U.S.A., Inc.; and Merck KGaA are some of the major players offering services for vaccine development.
Browse related reports by Grand View Research:
Kidney Cancer Drugs Market- The Global kidney cancer drugs market is expected to grow at an estimated CAGR of 17% over the forecast period. Renal cell carcinoma (RCC) is the most common form of cancer found in the kidney.
Hormone Replacement Therapy (HRT) Market - The global hormone replacement therapy market size was valued at USD 15.1 billion in 2014 and is expected to grow at a CAGR of 8.2% over the next seven years.
Wound dressing Market - The global wound dressing market size was valued at USD 9,163.4 million in 2014 and is expected to grow at a CAGR of 4.4% over the forecast period.
Grand View Research has segmented the global vaccine contract manufacturing market on the basis of vaccine type, workflow, application, and region:
Vaccine Contract Manufacturing Vaccine Type Outlook (Revenue, USD Million, 2014 - 2025)
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference.
On April 26, 2024, the hearing will commence 11:15 a.m.
Members of the public may observe the hearing by videoconference, by...
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...